Pilot Study on BP1.4979 Effect on Binge Eating Disorders
Status:
Not yet recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
This pilot study is to assess the efficacy and safety of BP1.4979 15 mg BID in female
patients with moderate to severe binge eating disorder (BED), as defined according to DSM-5
guidelines.